{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 61, "title": "Chairman, CEO & President", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 6731433, "exercisedValue": 0, "unexercisedValue": 64735872}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 65, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 3069385, "exercisedValue": 0, "unexercisedValue": 1429055}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 56, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 61, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 3402742, "exercisedValue": 0, "unexercisedValue": 9008793}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 57, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 3243134, "exercisedValue": 0, "unexercisedValue": 5928890}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 49, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Justin G. Claeys", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan P. Graham J.D.", "age": 63, "title": "Executive VP, General Counsel & Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 2440307, "exercisedValue": 0, "unexercisedValue": 2105468}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 2, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 306.92, "open": 305.41, "dayLow": 300.1, "dayHigh": 306.76, "regularMarketPreviousClose": 306.92, "regularMarketOpen": 305.41, "regularMarketDayLow": 300.1, "regularMarketDayHigh": 306.76, "dividendRate": 9.52, "dividendYield": 3.1, "exDividendDate": 1747353600, "payoutRatio": 1.1905, "fiveYearAvgDividendYield": 2.99, "beta": 0.524, "trailingPE": 40.490067, "forwardPE": 14.789551, "volume": 1906789, "regularMarketVolume": 1906789, "averageVolume": 3132393, "averageVolume10days": 3121910, "averageDailyVolume10Day": 3121910, "bid": 288.93, "ask": 317.26, "bidSize": 1, "askSize": 1, "marketCap": 164223565824, "fiftyTwoWeekLow": 253.3, "fiftyTwoWeekHigh": 346.85, "priceToSalesTrailing12Months": 4.913343, "fiftyDayAverage": 302.804, "twoHundredDayAverage": 306.7803, "trailingAnnualDividendRate": 9.0, "trailingAnnualDividendYield": 0.0293236, "currency": "USD", "tradeable": false, "enterpriseValue": 213784936448, "profitMargins": 0.122370005, "floatShares": 535679281, "sharesOutstanding": 537204992, "sharesShort": 15062987, "sharesShortPriorMonth": 16076993, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.027999999, "heldPercentInsiders": 0.00215, "heldPercentInstitutions": 0.82016, "shortRatio": 4.87, "shortPercentOfFloat": 0.028099999, "impliedSharesOutstanding": 537204992, "bookValue": 10.946, "priceToBook": 27.92801, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.183, "netIncomeToCommon": 4089999872, "trailingEps": 7.55, "forwardEps": 20.67, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.396, "enterpriseToEbitda": 14.105, "52WeekChange": 0.14028871, "SandP52WeekChange": 0.101756096, "lastDividendValue": 2.38, "lastDividendDate": 1739491200, "quoteType": "EQUITY", "currentPrice": 305.7, "targetHighPrice": 389.0, "targetLowPrice": 185.0, "targetMeanPrice": 315.94885, "targetMedianPrice": 324.0, "recommendationMean": 2.41935, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 11973000192, "totalCashPerShare": 22.288, "ebitda": 15157000192, "totalDebt": 60878999552, "quickRatio": 0.843, "currentRatio": 1.257, "totalRevenue": 33423998976, "debtToEquity": 1035.886, "revenuePerShare": 62.242, "returnOnAssets": 0.064, "returnOnEquity": 0.67553, "grossProfits": 22965999616, "freeCashflow": 13725875200, "operatingCashflow": 11489999872, "earningsGrowth": -0.187, "revenueGrowth": 0.109, "grossMargins": 0.68711, "ebitdaMargins": 0.45348, "operatingMargins": 0.51805, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "marketState": "PREPRE", "corporateActions": [], "postMarketTime": 1743638001, "regularMarketTime": 1743624000, "averageDailyVolume3Month": 3132393, "fiftyTwoWeekLowChange": 52.40001, "fiftyTwoWeekLowChangePercent": 0.20686936, "fiftyTwoWeekRange": "253.3 - 346.85", "fiftyTwoWeekHighChange": -41.149994, "fiftyTwoWeekHighChangePercent": -0.11863916, "fiftyTwoWeekChangePercent": 14.028872, "dividendDate": 1749168000, "earningsTimestamp": 1738702868, "earningsTimestampStart": 1746010740, "earningsTimestampEnd": 1746446400, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7.55, "epsForward": 20.67, "epsCurrentYear": 20.64053, "priceEpsCurrentYear": 14.810667, "fiftyDayAverageChange": 2.8960266, "fiftyDayAverageChangePercent": 0.009564031, "twoHundredDayAverageChange": -1.0802917, "twoHundredDayAverageChangePercent": -0.0035213856, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "postMarketChangePercent": 0.399084, "postMarketPrice": 306.92, "postMarketChange": 1.22, "regularMarketChange": -1.2200012, "regularMarketDayRange": "300.1 - 306.76", "fullExchangeName": "NasdaqGS", "regularMarketChangePercent": -0.3974981, "regularMarketPrice": 305.7, "displayName": "Amgen", "trailingPegRatio": 1.041}